James Mazzo has been appointed executive chairman at Neurotech Pharmaceuticals, where he will engage with the Neurotech team to advance the company’s technology platform toward market availability. Mazzo was recently named chairman and CEO of AcuFocus, a Versant portfolio company. He holds a B.S. in zoology from California State University of Long Beach. •
